⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1541745 | 1.00 | — | — | |
| SCHEMBL1592631 | 1.00 | — | — | |
| SCHEMBL5986034 | 0.97 | — | — | |
| SCHEMBL5987428 | 0.97 | — | — | |
| SCHEMBL5985630 | 0.97 | — | — | |
| SCHEMBL563888 | 0.97 | — | — | |
| SCHEMBL5984747 | 0.97 | — | — | |
| SCHEMBL5986830 | 0.97 | — | — | |
| SCHEMBL5984987 | 0.97 | — | — | |
| SCHEMBL5984865 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240197724-A1 | THERAPEUTIC AGENT FOR GAIT DISTURBANCE | NIPPON SHINYAKU CO., LTD. (JP) | 2024-06-20 | — | — | US | disclosed |
| EP-4316489-A1 | THERAPEUTIC AGENT FOR GAIT DISTURBANCE | Nippon Shinyaku Co., Ltd. (JP) | 2024-02-07 | — | — | EP | disclosed |
| CN-117157075-A | Remedies for gait disorder | 日本新药株式会社 | 2023-12-01 | — | — | CN | disclosed |
| WO-2023192286-A2 | ALKENYL SUCCINIMIDE COMPOUNDS AND THEIR USE | VERTELLUS HOLDINGS LLC (US) | 2023-10-05 | — | — | WO | disclosed |
| WO-2023085299-A1 | CATIONIC LIPID | 武田薬品工業株式会社 | 2023-05-19 | — | — | WO | disclosed |
| EP-3356457-B2 | PLASTICIZER COMPOSITION CONTAINING POLYMERIC DICARBOXYLIC ACID ESTERS AND 1,2-CYCLOHEXANE DICARBOXYLIC ACID ESTERS | BASF SE (DE) | 2022-12-21 | — | — | EP | disclosed |
| WO-2022211052-A1 | THERAPEUTIC AGENT FOR GAIT DISTURBANCE | 日本新薬株式会社 | 2022-10-06 | — | — | WO | disclosed |
| EP-3386473-B1 | OLIGOESTER AMMONIUM SALTS AND THEIR USE IN COSMETIC COMPOSITIONS | CLARIANT INT LTD (CH) | 2022-04-20 | — | — | EP | disclosed |
| US-20220016102-A1 | ER PROTEIN REGULATORS AND USE THEREOF | SHANGHAITECH UNIVERSITY (CN) | 2022-01-20 | — | — | US | disclosed |
| EP-2610308-B1 | USE OF POLYCARBOSILANE AS DISPERSANT FOR FLUOROPOLYMERS IN POLYCARBONATE RESINS | MITSUBISHI ENG PLASTICS CORP (JP) | 2020-07-15 | — | — | EP | disclosed |
| EP-0421441-A2 | Pantothenic acid derivatives | FUJIREBIO INC. (JP) | 1991-04-10 | — | — | EP | disclosed |
| US-4997848-A | Enzyme inhibitors | SANKYO COMPANY, LIMITED (JP) | 1991-03-05 | — | — | US | disclosed |
| EP-0314435-A2 | Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition, processes for their preparation and compositions containing them | Sankyo Company Limited (JP) | 1989-05-03 | — | — | EP | disclosed |
| US-4782160-A | CALCIUM RECEPTOR ANTAGONISTS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1988-11-01 | — | — | US | disclosed |
| EP-0276552-A1 | 1,4-dihydropyridine derivatives and their production | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1988-08-03 | — | — | EP | disclosed |
| US-4606933-A | Acrylate-functional organopolysiloxanes | SWS SILICONES CORPORATION (US) | 1986-08-19 | — | — | US | disclosed |
| US-4444928-A | NONHYDROLYZING LIGHT STABILIZERS FOR POLYMERS | CIBA-GEIGY CORPORATION (US) | 1984-04-24 | — | — | US | disclosed |
| US-4155992-A | SUSTAINED RELEASE | ALZA CORPORATION (US) | 1979-05-22 | — | — | US | disclosed |
| US-4079038-A | HAVING RECURRING DIOXYCARBON MOIETIES | ALZA CORPORATION (US) | 1978-03-14 | — | — | US | disclosed |
| US-4070347-A | Poly(orthoester) co- and homopolymers and poly(orthocarbonate) co- and homopolymers having carbonyloxy functionality | ALZA CORPORATION (US) | 1978-01-24 | — | — | US | disclosed |